Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle

BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T an...

Full description

Saved in:
Bibliographic Details
Published inCirculation. Arrhythmia and electrophysiology Vol. 2; no. 5; pp. 548 - 554
Main Authors Borleffs, C Jan Willem, Scherptong, Roderick W.C., Man, Sum-Che, van Welsenes, Guido H., Bax, Jeroen J., van Erven, Lieselot, Swenne, Cees A., Schalij, Martin J.
Format Journal Article
LanguageEnglish
Published Hagerstown, MD American Heart Association, Inc 01.10.2009
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text
ISSN1941-3149
1941-3084
1941-3084
DOI10.1161/CIRCEP.109.859108

Cover

Abstract BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. METHODS AND RESULTS—ICD patients (n=412, 361 men; age, 63±11 years) with ischemic heart disease and a left ventricular ejection fraction ≤40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤90° (n=124, 30%) with patients with a planar QRS-T angle >90° before device implantation. Furthermore, patients with a spatial QRS-T angle ≤100° (n=56, 14%) were compared with patients with a spatial QRS-T angle >100°, before implantation. For patients with a planar QRS-T angle >90° as compared with ≤90°, the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100° was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle ≤100° exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. CONCLUSIONS—A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle ≤100° might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.
AbstractList In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease.BACKGROUNDIn patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease.ICD patients (n=412, 361 men; age, 63+/-11 years) with ischemic heart disease and a left ventricular ejection fraction < or = 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle < or = 90 degrees (n=124, 30%) with patients with a planar QRS-T angle >90 degrees before device implantation. Furthermore, patients with a spatial QRS-T angle < or = 100 degrees (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 degrees , before implantation. For patients with a planar QRS-T angle >90 degrees as compared with < or = 90 degrees , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 degrees was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle < or = 100 degrees exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up.METHODS AND RESULTSICD patients (n=412, 361 men; age, 63+/-11 years) with ischemic heart disease and a left ventricular ejection fraction < or = 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle < or = 90 degrees (n=124, 30%) with patients with a planar QRS-T angle >90 degrees before device implantation. Furthermore, patients with a spatial QRS-T angle < or = 100 degrees (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 degrees , before implantation. For patients with a planar QRS-T angle >90 degrees as compared with < or = 90 degrees , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 degrees was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle < or = 100 degrees exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up.A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle < or = 100 degrees might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.CONCLUSIONSA wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle < or = 100 degrees might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.
BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. METHODS AND RESULTS—ICD patients (n=412, 361 men; age, 63±11 years) with ischemic heart disease and a left ventricular ejection fraction ≤40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤90° (n=124, 30%) with patients with a planar QRS-T angle >90° before device implantation. Furthermore, patients with a spatial QRS-T angle ≤100° (n=56, 14%) were compared with patients with a spatial QRS-T angle >100°, before implantation. For patients with a planar QRS-T angle >90° as compared with ≤90°, the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100° was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle ≤100° exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. CONCLUSIONS—A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle ≤100° might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.
Background— In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. Methods and Results— ICD patients (n=412, 361 men; age, 63 11 years) with ischemic heart disease and a left ventricular ejection fraction ≤40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤90 (n=124, 30%) with patients with a planar QRS-T angle >90 before device implantation. Furthermore, patients with a spatial QRS-T angle ≤100 (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 , before implantation. For patients with a planar QRS-T angle >90 as compared with ≤90 , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle ≤100 exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. Conclusions— A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle ≤100 might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.
In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. ICD patients (n=412, 361 men; age, 63+/-11 years) with ischemic heart disease and a left ventricular ejection fraction < or = 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle < or = 90 degrees (n=124, 30%) with patients with a planar QRS-T angle >90 degrees before device implantation. Furthermore, patients with a spatial QRS-T angle < or = 100 degrees (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 degrees , before implantation. For patients with a planar QRS-T angle >90 degrees as compared with < or = 90 degrees , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 degrees was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle < or = 100 degrees exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle < or = 100 degrees might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.
Author Bax, Jeroen J.
van Welsenes, Guido H.
van Erven, Lieselot
Scherptong, Roderick W.C.
Schalij, Martin J.
Borleffs, C Jan Willem
Swenne, Cees A.
Man, Sum-Che
AuthorAffiliation From the Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
AuthorAffiliation_xml – name: From the Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Author_xml – sequence: 1
  givenname: C
  surname: Borleffs
  middlename: Jan Willem
  fullname: Borleffs, C Jan Willem
  organization: From the Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 2
  givenname: Roderick
  surname: Scherptong
  middlename: W.C.
  fullname: Scherptong, Roderick W.C.
– sequence: 3
  givenname: Sum-Che
  surname: Man
  fullname: Man, Sum-Che
– sequence: 4
  givenname: Guido
  surname: van Welsenes
  middlename: H.
  fullname: van Welsenes, Guido H.
– sequence: 5
  givenname: Jeroen
  surname: Bax
  middlename: J.
  fullname: Bax, Jeroen J.
– sequence: 6
  givenname: Lieselot
  surname: van Erven
  fullname: van Erven, Lieselot
– sequence: 7
  givenname: Cees
  surname: Swenne
  middlename: A.
  fullname: Swenne, Cees A.
– sequence: 8
  givenname: Martin
  surname: Schalij
  middlename: J.
  fullname: Schalij, Martin J.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22283768$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19843923$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URD_gB3BBviBOWew4Tmxuq3RpV6rEUgocI8eZNAbHWWyHqif-OoZsQeKAJcsz8vOOZuY9RUducoDQc0pWlJb0db29rje7FSVyJbikRDxCJ1QWNGNEFEcPMS3kMToN4QshJRW0fIKOqRQFkzk7QT92Hjqjo3G3-BO46I2erfJ47f1wH4fRqICNwzsVTfoN-LOJA94GPcBoNL4E5SM-NwFUgDe4tsYZrSxe7_c2BdFMDk89jgPgTX2RnYM336HD768_ZDd47W4tPEWPe2UDPDu8Z-jj281NfZldvbvY1uurTBep60yRljJNWNfyvOg6TmXecyVa3WvSsZ7zlotKKcGF0FXLCFG54gmQIidQli07Q6-Wuns_fZshxGY0QYO1ysE0h6ZiBZEVqWQiXxzIuR2ha_bejMrfNw87S8DLA6BCGrb3ymkT_nB5ngtWlSJxdOG0n0Lw0P8tRZpf_jWLfymVzeJf0lT_aLSJv_cYvTL2v8piUd5NNoIPX-18B74ZQNk4NIQyVhWSZTkhCU8nS5dS9hNe2a4P
CitedBy_id crossref_primary_10_1016_j_ajem_2022_05_034
crossref_primary_10_33667_2078_5631_2023_22_36_42
crossref_primary_10_1016_j_jelectrocard_2015_04_014
crossref_primary_10_23736_S2724_5683_20_05166_X
crossref_primary_10_1016_j_hrthm_2014_09_044
crossref_primary_10_1253_circj_CJ_24_0269
crossref_primary_10_7759_cureus_28506
crossref_primary_10_1016_j_jelectrocard_2017_02_008
crossref_primary_10_51847_GzeDdExlEH
crossref_primary_10_1016_j_ijcard_2016_05_005
crossref_primary_10_4274_terh_galenos_2022_82335
crossref_primary_10_1186_s12872_023_03421_6
crossref_primary_10_1016_j_hroo_2025_02_005
crossref_primary_10_18621_eurj_1144126
crossref_primary_10_1016_j_jelectrocard_2013_09_003
crossref_primary_10_1016_j_jelectrocard_2022_09_001
crossref_primary_10_1007_s00380_019_01380_7
crossref_primary_10_1016_j_jelectrocard_2018_08_028
crossref_primary_10_1111_anec_70013
crossref_primary_10_1007_s12012_020_09579_1
crossref_primary_10_1161_JAHA_117_008160
crossref_primary_10_1007_s10840_018_0342_2
crossref_primary_10_1186_s12872_017_0631_1
crossref_primary_10_1681_ASN_2015080916
crossref_primary_10_5144_0256_4947_2012_372
crossref_primary_10_1093_europace_eus306
crossref_primary_10_1093_ndt_gfq247
crossref_primary_10_1016_j_jdiacomp_2016_12_001
crossref_primary_10_1016_j_jelectrocard_2016_10_001
crossref_primary_10_4103_0366_6999_187844
crossref_primary_10_1007_s00380_020_01585_1
crossref_primary_10_1016_j_jelectrocard_2013_07_005
crossref_primary_10_1016_j_jelectrocard_2022_10_008
crossref_primary_10_1093_ehjdh_ztae048
crossref_primary_10_1159_000509766
crossref_primary_10_1097_MCA_0000000000000935
crossref_primary_10_51582_interconf_19_20_04_2022_028
crossref_primary_10_1016_j_jelectrocard_2020_05_013
crossref_primary_10_1155_2020_6027405
crossref_primary_10_33678_cor_2023_030
crossref_primary_10_1016_j_jacc_2022_12_024
crossref_primary_10_1016_j_jelectrocard_2010_07_017
crossref_primary_10_1016_j_jelectrocard_2011_04_007
crossref_primary_10_1016_j_echo_2013_08_023
crossref_primary_10_2139_ssrn_4143707
crossref_primary_10_1109_ACCESS_2023_3256721
crossref_primary_10_1371_journal_pone_0171069
crossref_primary_10_1177_00912174231184759
crossref_primary_10_1016_j_jelectrocard_2019_09_028
crossref_primary_10_1017_S1047951116000640
crossref_primary_10_1016_j_amjcard_2013_01_294
crossref_primary_10_3390_diagnostics15020187
crossref_primary_10_3390_s22145414
crossref_primary_10_1016_j_jelectrocard_2017_12_038
crossref_primary_10_1097_MCA_0000000000001061
crossref_primary_10_1038_s41598_022_22501_9
crossref_primary_10_1002_clc_22707
crossref_primary_10_1371_journal_pone_0136174
crossref_primary_10_1016_j_jelectrocard_2014_11_009
crossref_primary_10_51262_ejtox_1206665
crossref_primary_10_1016_j_amjcard_2014_01_406
crossref_primary_10_1016_j_jelectrocard_2016_07_025
crossref_primary_10_1111_anec_12310
crossref_primary_10_1016_j_amjcard_2019_03_018
crossref_primary_10_1111_anec_12276
crossref_primary_10_1016_j_cellimm_2021_104427
crossref_primary_10_1016_j_jelectrocard_2010_03_009
crossref_primary_10_1002_clc_22549
crossref_primary_10_1016_j_jacep_2016_08_007
crossref_primary_10_1016_j_jelectrocard_2018_05_011
crossref_primary_10_1007_s00592_013_0483_9
crossref_primary_10_1093_ehjdh_ztad045
crossref_primary_10_34883_PI_2020_12_5_001
crossref_primary_10_1111_anec_12390
crossref_primary_10_1111_anec_13082
crossref_primary_10_1111_anec_12264
crossref_primary_10_1016_j_jelectrocard_2010_03_010
crossref_primary_10_1016_j_jelectrocard_2015_07_016
crossref_primary_10_1016_j_jelectrocard_2011_01_001
crossref_primary_10_1016_j_hrthm_2010_10_017
crossref_primary_10_1016_j_ijcard_2021_10_139
crossref_primary_10_3389_fped_2022_917730
crossref_primary_10_1260_2040_2295_4_2_167
crossref_primary_10_1111_anec_70062
crossref_primary_10_1111_pace_12365
crossref_primary_10_1016_j_bspc_2020_102305
crossref_primary_10_1016_j_jelectrocard_2020_10_009
crossref_primary_10_1093_europace_eur393
crossref_primary_10_1016_j_jelectrocard_2020_02_001
crossref_primary_10_1016_j_cvdhj_2023_11_003
crossref_primary_10_1016_j_jelectrocard_2023_02_003
crossref_primary_10_1007_s10840_011_9661_2
crossref_primary_10_1093_ndt_gft347
crossref_primary_10_1097_MD_0000000000032320
crossref_primary_10_1111_anec_12579
crossref_primary_10_1016_j_advms_2016_11_008
crossref_primary_10_1016_j_cardfail_2017_11_001
crossref_primary_10_1016_j_amjcard_2011_11_027
crossref_primary_10_3390_electronics13020326
crossref_primary_10_31832_smj_916225
crossref_primary_10_1111_anec_12051
crossref_primary_10_1007_s00059_020_04978_0
crossref_primary_10_1002_ehf2_12746
crossref_primary_10_28982_josam_641533
crossref_primary_10_1016_j_jelectrocard_2015_05_002
crossref_primary_10_1016_j_jelectrocard_2016_07_015
crossref_primary_10_1016_j_jelectrocard_2015_05_004
crossref_primary_10_1111_anec_12206
crossref_primary_10_1186_s12872_017_0696_x
crossref_primary_10_1016_j_amjcard_2011_09_014
crossref_primary_10_1016_j_amjcard_2014_05_011
Cites_doi 10.1016/0735-1097(95)00599-4
10.1016/j.amjcard.2005.04.046
10.1111/j.1540-8167.2006.00680.x
10.1016/j.hrthm.2005.08.031
10.1056/NEJM198308113090602
10.1016/j.jacc.2008.05.058
10.1016/j.hrthm.2006.05.025
10.1016/j.jelectrocard.2008.07.006
10.1056/NEJMra000650
10.1111/j.1540-8167.2006.00526.x
10.1056/NEJM199912163412503
10.1016/j.jelectrocard.2006.11.003
10.1161/circ.98.21.2334
10.1001/jama.295.16.1901
10.1161/circualtionaha.108.189742
10.1161/circulationaha.104.526673
10.1016/j.hrthm.2004.10.040
10.1056/NEJM199612263352601
10.1007/BF03085968
10.1161/circulationaha.107.733451
10.1056/NEJMoa013474
10.1056/NEJMoa043399
10.1161/circ.98.7.663
10.1161/circulationaha.107.189375
10.1016/S0195-668X(03)00203-3
10.1161/01.cir.0000129322.97266.f3
10.1016/j.hrthm.2004.02.009
10.1016/j.amjcard.2005.08.052
10.1056/NEJMoa032423
10.1161/01.cir.0000150390.04704.b7
10.1161/circ.102.11.1252
ContentType Journal Article
Copyright 2009 American Heart Association, Inc.
2015 INIST-CNRS
Copyright_xml – notice: 2009 American Heart Association, Inc.
– notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIRCEP.109.859108
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1941-3084
EndPage 554
ExternalDocumentID 19843923
22283768
10_1161_CIRCEP_109_859108
01337493-200910000-00011
Genre Journal Article
GroupedDBID ---
.XZ
.Z2
18M
53G
5VS
6J9
AAAAV
AAHPQ
AAIQE
AAJCS
AARTV
AASCR
ABASU
ABBUW
ABDIG
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
ADNKB
AEBDS
AEETU
AFBFQ
AFDTB
AFEXH
AFNMH
AFUWQ
AGINI
AHQNM
AHQVU
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BQLVK
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H13
HLJTE
IKREB
IN~
IPNFZ
KD2
KQ8
KQB
L-C
ODMTH
ODZKP
OHYEH
OK1
OPUJH
OUVQU
OVD
OVDNE
OXXIT
RAH
RIG
RLZ
S4S
TEORI
TR2
TSPGW
V2I
W2D
W3M
W8F
WOW
ZZMQN
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
ADKSD
ID FETCH-LOGICAL-c4061-a0b13c03db524dd5192f5a8bcfc0d3f55b587aa8588c7b300a2a55a89820e66b3
ISSN 1941-3149
1941-3084
IngestDate Mon Sep 08 16:16:17 EDT 2025
Wed Feb 19 01:46:14 EST 2025
Mon Jul 21 09:14:50 EDT 2025
Thu Apr 24 23:11:01 EDT 2025
Tue Jul 01 01:19:06 EDT 2025
Fri May 16 03:46:54 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords ventricular arrhythmia
Prognosis
Arrhythmia
QRS interval
ischemic heart disease
Cardiovascular disease
Cardioversion
Myocardial ischemia
Male
Epidemiology
Myocardial disease
Incidence
Result
Vascular disease
Prevention
Electrodiagnosis
Primary
Electrocardiography
primary prevention
Ventricular ejection
Stratification
Age
Hazard
implantable cardioverter-defibrillator
Human
Intensive cardiocirculatory care
Critically ill
Mortality
Prediction
Instrumentation therapy
Method
Coronary heart disease
Left ventricle
Angle
Low
Implanted
Risk factor
Hemodynamics
Technique
Predictive factor
Application
Defibrillator
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4061-a0b13c03db524dd5192f5a8bcfc0d3f55b587aa8588c7b300a2a55a89820e66b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19843923
PQID 734097079
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_734097079
pubmed_primary_19843923
pascalfrancis_primary_22283768
crossref_primary_10_1161_CIRCEP_109_859108
crossref_citationtrail_10_1161_CIRCEP_109_859108
wolterskluwer_health_01337493-200910000-00011
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-October
PublicationDateYYYYMMDD 2009-10-01
PublicationDate_xml – month: 10
  year: 2009
  text: 2009-October
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Circulation. Arrhythmia and electrophysiology
PublicationTitleAlternate Circ Arrhythm Electrophysiol
PublicationYear 2009
Publisher American Heart Association, Inc
Lippincott Williams & Wilkins
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott Williams & Wilkins
References e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
(e_1_3_2_23_2) 2006; 33
e_1_3_2_24_2
e_1_3_2_25_2
(e_1_3_2_26_2) 2005; 32
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
References_xml – ident: e_1_3_2_5_2
  doi: 10.1016/0735-1097(95)00599-4
– ident: e_1_3_2_17_2
  doi: 10.1016/j.amjcard.2005.04.046
– ident: e_1_3_2_19_2
  doi: 10.1111/j.1540-8167.2006.00680.x
– ident: e_1_3_2_25_2
  doi: 10.1016/j.hrthm.2005.08.031
– ident: e_1_3_2_4_2
  doi: 10.1056/NEJM198308113090602
– ident: e_1_3_2_16_2
  doi: 10.1016/j.jacc.2008.05.058
– ident: e_1_3_2_30_2
  doi: 10.1016/j.hrthm.2006.05.025
– volume: 33
  start-page: 849
  year: 2006
  ident: e_1_3_2_23_2
  publication-title: Comput Cardiol
– ident: e_1_3_2_27_2
  doi: 10.1016/j.jelectrocard.2008.07.006
– ident: e_1_3_2_1_2
  doi: 10.1056/NEJMra000650
– ident: e_1_3_2_18_2
  doi: 10.1111/j.1540-8167.2006.00526.x
– ident: e_1_3_2_8_2
  doi: 10.1056/NEJM199912163412503
– ident: e_1_3_2_29_2
  doi: 10.1016/j.jelectrocard.2006.11.003
– ident: e_1_3_2_3_2
  doi: 10.1161/circ.98.21.2334
– ident: e_1_3_2_12_2
  doi: 10.1001/jama.295.16.1901
– ident: e_1_3_2_11_2
  doi: 10.1161/circualtionaha.108.189742
– ident: e_1_3_2_15_2
  doi: 10.1161/circulationaha.104.526673
– ident: e_1_3_2_21_2
  doi: 10.1016/j.hrthm.2004.10.040
– ident: e_1_3_2_9_2
  doi: 10.1056/NEJM199612263352601
– ident: e_1_3_2_28_2
  doi: 10.1007/BF03085968
– ident: e_1_3_2_22_2
  doi: 10.1161/circulationaha.107.733451
– volume: 32
  start-page: 515
  year: 2005
  ident: e_1_3_2_26_2
  publication-title: Comput Cardiol
– ident: e_1_3_2_10_2
  doi: 10.1056/NEJMoa013474
– ident: e_1_3_2_6_2
  doi: 10.1056/NEJMoa043399
– ident: e_1_3_2_14_2
  doi: 10.1161/circ.98.7.663
– ident: e_1_3_2_31_2
  doi: 10.1161/circulationaha.107.189375
– ident: e_1_3_2_20_2
  doi: 10.1016/S0195-668X(03)00203-3
– ident: e_1_3_2_2_2
  doi: 10.1161/01.cir.0000129322.97266.f3
– ident: e_1_3_2_24_2
  doi: 10.1016/j.hrthm.2004.02.009
– ident: e_1_3_2_32_2
  doi: 10.1016/j.amjcard.2005.08.052
– ident: e_1_3_2_7_2
  doi: 10.1056/NEJMoa032423
– ident: e_1_3_2_13_2
  doi: 10.1161/01.cir.0000150390.04704.b7
– ident: e_1_3_2_33_2
  doi: 10.1161/circ.102.11.1252
SSID ssj0061816
Score 2.2882445
Snippet BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias...
Background— In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias...
In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD...
SourceID proquest
pubmed
pascalfrancis
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 548
SubjectTerms Arrhythmias, Cardiac - etiology
Arrhythmias, Cardiac - mortality
Arrhythmias, Cardiac - physiopathology
Arrhythmias, Cardiac - prevention & control
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Cardiovascular system
Coronary heart disease
Defibrillators, Implantable
Electrocardiography - methods
Female
Heart
Humans
Investigative techniques of hemodynamics
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Middle Aged
Myocardial Ischemia - complications
Predictive Value of Tests
Primary Prevention
Proportional Hazards Models
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Survival Analysis
Title Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01337493-200910000-00011
https://www.ncbi.nlm.nih.gov/pubmed/19843923
https://www.proquest.com/docview/734097079
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FIiEkhFhLWKo5cCJy8L5wK1G6QFtKSNTcrJnxmFhN7chxQHDhD_EjebPYcdSI7WJFo3HGzvsy85bvvYfQS0qcQPBwDc4c33BDTo2IeZZBmcldDkcKZcI1cHrmH03cd1Nv2un8bLGWVhXts-9b80r-R6owBnIVWbL_INnmS2EAPoN84QoShutfyfi8FGEWSVwWtEXpyyNlj5Tl7Fs1u8qIIomr0qk6jy0Dc1YS4kUr66oO0AjHQJMk2Qpq1xSC4eDQSOCVvoB--nH0yRj3SP55vlnnICuZ7gXW7-03jyCjE7rZjnSjbPjx3xblnKeKuigou5LFM9fuZBkfAkwtKs0bHonGbRm77F2snbun2oO7ujIGswalIivrQhz7uhPB4SpLCp2IUfs4ooYtV2_LkSu8ZKqZXJ9vGdN7ud2CrNfalz1VzvP6eeGL82JwPBoMz0Vlrb4o52eG68OxJgScfYgPJicn8Xg4Hd9AN-0ANDWhgh-_r899H4Atc9nq59IxdFji9bUFNrSgOwuyBOmmqpPKNlMH5nwtBHtieSmTJ1oq0PgeuqttF7yvgHgfdXj-AN061eyMh-jHGo-4hUfcwiPOclzjEQs84hqPWOIRazy-wTUacQuNuEgxoBG30IglGrFE4yM0ORiOB0eGbvBhMKFHGsSklsNMJ6Ge7SYJGBN26pGQspSZiZN6HvXCgJDQC0MWUMc0iU08mBCB2sp9nzqP0U5e5PwJwsT3eEJs36Kh5TJCojQkKU0iTnhoBYx3kVn_4DHT1e9FE5Z5LK1g34qVjAQjI1Yy6qJXzS0LVfrld5P3NqTY3GHL-lI-TMC1WGPYwUVYjuS8WC3jwBE158wg6qJdJe71clEIBoPtdJGxIf9YJUnHYL85gRs5YleMZKTOkEbe0z8v9gzdXv_TnqOdqlzxF6BfV3RPwvoXYmHUIg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+ventricular+arrhythmias+in+patients+with+ischemic+heart+disease%3A+clinical+application+of+the+ECG-derived+QRS-T+angle&rft.jtitle=Circulation.+Arrhythmia+and+electrophysiology&rft.au=Borleffs%2C+C+Jan+Willem&rft.au=Scherptong%2C+Roderick+W+C&rft.au=Man%2C+Sum-Che&rft.au=van+Welsenes%2C+Guido+H&rft.date=2009-10-01&rft.issn=1941-3084&rft.eissn=1941-3084&rft.volume=2&rft.issue=5&rft.spage=548&rft_id=info:doi/10.1161%2FCIRCEP.109.859108&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-3149&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-3149&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-3149&client=summon